Presentation is loading. Please wait.

Presentation is loading. Please wait.

Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber  Thomas Werfel, MD, Annice Heratizadeh, MD, Margarete.

Published byDorothea Dunkle Modified over 5 years ago

Similar presentations

Presentation on theme: "Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber  Thomas Werfel, MD, Annice Heratizadeh, MD, Margarete."— Presentation transcript:

1 Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber 
Thomas Werfel, MD, Annice Heratizadeh, MD, Margarete Niebuhr, MD, Alexander Kapp, MD, Lennart Matthias Roesner, PhD, Annika Karch, MSc, Veit J. Erpenbeck, MD, PhD, Christian Lösche, MD, Thomas Jung, MD, Norbert Krug, MD, Philipp Badorrek, MD, Jens M. Hohlfeld, MD  Journal of Allergy and Clinical Immunology  Volume 136, Issue 1, Pages e9 (July 2015) DOI: /j.jaci Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Flow chart of the study.
Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Course of objective SCORAD scores. This figure is based on the PP population. In the verum group 1 patient was excluded from further statistical analysis from postchallenge day 2 onward. In the placebo group 1 patient was excluded from day 4. *P < .05 and **P < .01. P values are derived from paired comparisons against the respective prechallenge values (each treatment group separately). The box and whisker diagram illustrates the smallest value, the lower quartile, the median, the upper quartile, and the sample maximum of the data series. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Time course of worsening of eczema in air-exposed skin from prechallenge day 1 until postchallenge day 5, as assessed by local SCORAD scores, in the verum and placebo groups (box and whisker diagram). *P < .05 and **P < .01. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 Photodocumentation before (left panels) and after (right panels) grass pollen challenge of 2 patients of the open-label study phase B. A, Prechallenge day 1 versus postchallenge day 2. B, Screening versus postchallenge day 3. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig E1 The increase in objective SCORAD score from prechallenge day 1 (baseline) to postchallenge day 3 was significantly higher in the verum group (P = .010, analysis of covariance). The box and whisker diagram illustrates the smallest value, the lower quartile, the median, the upper quartile, and the sample maximum of the data series. *P < .05. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig E2 Difference in objective SCORAD scores from prechallenge day 1 to postchallenge day 5 (box and whisker diagram). The increase in points is significantly higher in the verum group (P = .042, Mann-Whitney rank sum test). *P < .05. Journal of Allergy and Clinical Immunology  , e9DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber  Thomas Werfel, MD, Annice Heratizadeh, MD, Margarete."

Similar presentations

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis  Kristian Reich, MD, PhD, Julia Deinzer,

Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis  Kristian Reich, MD, PhD, Julia Deinzer,
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge  Grant C. Nicholson, BSc, Harsha H. Kariyawasam,

The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge  Grant C. Nicholson, BSc, Harsha H. Kariyawasam,
Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure  Philipp Badorrek, MD,

Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure  Philipp Badorrek, MD,
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.
Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,

Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,
Petasol butenoate complex (Ze 339) relieves allergic rhinitis–induced nasal obstruction more effectively than desloratadine  Alina F. Dumitru, MD, Mohamed.

Petasol butenoate complex (Ze 339) relieves allergic rhinitis–induced nasal obstruction more effectively than desloratadine  Alina F. Dumitru, MD, Mohamed.
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,
Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A

Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A
Vitamin D and antimicrobial peptide levels in patients with atopic dermatitis and atopic dermatitis complicated by eczema herpeticum: A pilot study  Lujain.

Vitamin D and antimicrobial peptide levels in patients with atopic dermatitis and atopic dermatitis complicated by eczema herpeticum: A pilot study  Lujain.
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.

Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.
Atopic dermatitis: Age and race do matter!

Atopic dermatitis: Age and race do matter!
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy  Gabriela Senti, MD, Nicole Graf, PhD, Susanne Haug, MD, Nadine.

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy  Gabriela Senti, MD, Nicole Graf, PhD, Susanne Haug, MD, Nadine.
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation.

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation.
Inflammatory marker analysis in psoriatic skin under topical phosphodiesterase 4 inhibitor treatment  Lennart M. Roesner, PhD, Petra Kienlin, Gabriele.

Inflammatory marker analysis in psoriatic skin under topical phosphodiesterase 4 inhibitor treatment  Lennart M. Roesner, PhD, Petra Kienlin, Gabriele.
Malassezia sympodialis thioredoxin–specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis  Hari Balaji, MSc, Annice Heratizadeh,

Malassezia sympodialis thioredoxin–specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis  Hari Balaji, MSc, Annice Heratizadeh,
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.

Similar presentations

Ads by Google